DCTN2 and cutaneous melanoma: The DCTN family has been linked to neurodegeneration (14, 15), and more and more studies have shown that DCTN2 may be a potential prognostic biomarker for cancer, including cutaneous melanoma, colon adenocarcinoma, and osteosarcoma (16–18).